Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0724 in acute middle cerebral artery stroke
NCT00401310Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Jul 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of arundic acid in ischemic stroke, sponsored by Merck & Co.. Started Jul 2007; status: terminated.
02
Drugs
arundic acid
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00401310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401310.